投融资数据库
免费查数据
注册送3天会员
首页>投融资
Alderley Analytical
收并购
Alderley Analytical is an independent Contract Research Organisation (CRO). We offer specialist bioanalytical services to support your drug development programmes, from discovery through to late stage clinical development, focusing on small molecules, large molecules, peptides, biologics and biomarkers.
Our biotech, pharma and CRO clients have discovered that keeping their bioanalysis with one provider means fewer laboratory transfers and no loss of bioanalytical knowledge of the molecule. By simplifying this process, it means less complications helping the rapid development of new drugs.
We take a flexible and responsive approach, using our collective expertise to develop novel bioanalytical methods and deliver your results on-time to the right quality. We also pride ourselves on excellent communication; you’ll find us easy to get hold of and we stay in touch, even if there’s no news to report.
As a GLP and GCP accredited laboratory, we can offer regulatory compliance where needed and are able to validate bioanalytical methods and deliver bioanalytical results to current FDA/EMA guidelines. Get in touch to discuss your bioanalysis requirements today.
Visit our website at www.alderleyanalytical.com for more information.
基本信息
-
公司全称Alderley Analytical Ltd
-
类型合同研究服务提供商
-
产业领域学术研究、综合服务
-
公司人数15~50人
-
地址Mereside Alderley Park MACCLESFIELD CHESHIRE SK10 4TG; GB; Telephone: +441625238610;
-
联系电话441625238610
-
邮箱info@alderleyanalytical.com
-
成立时间2014-01-01
相关投融资企业
B轮
VieCure构建了一个引擎,将数据转化为知识,并将世界上最好的想法实时传递给临床医生和患者。癌症治疗是一个复杂且不断变化的过程,尤其是随着肿瘤生物学的最新进展以及分子检测指导下的新疗法的开发和批准。VieCure的临床咨询委员会由来自顶级癌症项目、大学和研究所的全球领导者组成,他们审查临床证据、评估文献并研究肿瘤治疗,以开发算法和编码的临床规则,以便在VieCure中实施™ 人工智能平台。
PreA轮
孟眸生物成立于2023年3月,是一家专注于退行性眼科疾病新药研发的生物制药公司,致力于采用创新的干细胞及基因疗法治疗眼科疾病,有望解决包括干性黄斑变性在内的退行性眼科疾病无药可医的现状。目前,孟眸生物已建立包括诱导性多能干细胞(iPSC)体外诱导重编程及体外诱导分化和AAV载体优化等多项平台技术。独有的眼部类器官模型和大小动物疾病模型可以在早期对候选药物进行药效和安全性评价,加速眼科管线的开发。
B轮
Manifold是一个人工智能驱动的临床研究平台,简化了现代研究和数据管理的手工工作流程,使研究人员能够用更少的资源进行更多高影响力的研究和合作。该公司受到世界知名研究机构的信赖。我们的愿景是使进行现代研究的速度提高十倍,成本降低十分之一,从而揭示前所未有的见解。



浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息